Anal melanoma: a clinical challenge without therapeutic consensus

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anal melanoma is a rare malignancy, accounting for 0.4% to 1.6% of all melanomas. Its atypical presentation, low incidence, and non-specific symptoms make it a challenging diagnosis, which can lead to delayed treatment with an unfavorable impact on clinical outcomes. Treatment should be multidisciplinary and may include surgical resection with adjuvant therapy, chemotherapy, and radiotherapy. We present the case of a male patient who presented to the emergency department due to foreign body sensation and transanal bleeding. The patient underwent an anal exploration under anesthesia, where a hyperpigmented canal-dependent tumor lesion with extension into the perianal skin was found. After a wide local excision, histopathological study confirmed the diagnosis of invasive nodular melanoma. The patient was discharged without complications for follow-up and management in the outpatient medical oncology clinic.

Cite

CITATION STYLE

APA

Fuentes-Calvo, K. J., Alvarez-Bautista, F. E., Santes, O., De Nora-Jiménez, R., Arias-Ruíz, L. F., & Salgado-Nesme, N. (2025). Anal melanoma: a clinical challenge without therapeutic consensus. Journal of Surgical Case Reports, 2025(1). https://doi.org/10.1093/jscr/rjaf015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free